Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2017
University of California (San Francisco)Residency, Internal Medicine, 2010 - 2013
Stanford University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2012 - 2026
OR State Medical License 2021 - 2022
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder
The Oncologist. 2025-11-11 - Genomic Landscape and Outcomes of Renal Cell Carcinoma With Metastases to the Pancreas.Michael J Glover, Arya Ashok, Osama Khan, Chia-Sui Kao, Ryan Chiang
JCO Precision Oncology. 2025-11-01 - Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.Amanda Nizam, Charles B Nguyen, Jinju Li, Emily C Zabor, Pavlos Msaouel
Cancer Medicine. 2025-10-01
Press Mentions
Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity Among Patients with Cancer: A Report from the COVID-19 and Cancer ConsortiumMarch 18th, 2021
Pune Cancer Surgeon Dr Shah Receives National AwardFebruary 3rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
